Press "Enter" to skip to content

New patent for Aerie Pharms drug ROCKLATAN

2
Copyright © DrugPatentWatch. Originally published at New patent for Aerie Pharms drug ROCKLATAN

Annual Drug Patent Expirations for ROCKLATAN
Annual Drug Patent Expirations for ROCKLATAN

Rocklatan is a drug marketed by Aerie Pharms Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.

ROCKLATAN drug price trends.

This drug has fifty patent family members in eight countries.

The generic ingredient in ROCKLATAN is latanoprost; netarsudil dimesylate. One supplier is listed for this compound. Additional details are available on the latanoprost; netarsudil dimesylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Aerie Pharms drug ROCKLATAN
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions